InvestorsHub Logo
Followers 0
Posts 111
Boards Moderated 0
Alias Born 02/09/2017

Re: eicoman post# 27210

Sunday, 04/02/2017 2:40:58 PM

Sunday, April 02, 2017 2:40:58 PM

Post# of 30351
Eicoman.

Everything is possible. But let's be realists here. If you didn't trade this stock, you are showing a HUGE unrealized loss in your portfolio. Plain and simple. No two ways about it. I had to learn that the hard way, years ago, during the Bassam Damaj years.

Let's talk about Denner and Sarrisa.

Reverse split adjusted they bought 549,451 shares at $18.20 back in February 11, 2015. Then they bought 795,455 at $8.80 between in two closings dated January 12, 2016 and March 03, 2016 . His initial position in Apricus was bought in the open market and it was for 103,000 reverse split adjusted and the closing price for that quarter was $9.90. That makes his total amount of shares owned in Apricus 1,447,906.

His average cost per share is $12.44.

You guys think that he is in the non-profit business? Even non-profit businesses aren't non-profit. They pay themselves huge salaries and call their work charity work.

Look guys, I don't have the proof that it was him behind the moves these past months but he is in that type of business. He owns a Hedge fund. There are several ways to make money in this business and it's not always by stock going straight up.

At the end of the day, it really doesn't matter if the theory I brought forward has Sarissa Capital's name behind it. It can be any other hedge fund behind the moves. I just doubt that Sarissa Capital, being in this type of business would just sit on their hands while somebody broke in to their house and is eating at their table!

They say follow the money. Who has been the beneficiary of Apricus' tragedy? Ferring Pharmaceuticals! They were able to buy
assets for cents on the dollar!

It's hindsight, but who did Richard Pascoe benefit? Ferring or his own shareholders?








Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SEEL News